Microbix Biosystems Inc
TSX:MBX

Watchlist Manager
Microbix Biosystems Inc Logo
Microbix Biosystems Inc
TSX:MBX
Watchlist
Price: 0.305 CAD -1.61% Market Closed
Market Cap: 43m CAD

Wall Street
Price Targets

MBX Price Targets Summary
Microbix Biosystems Inc

Wall Street analysts forecast MBX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MBX is 0.918 CAD with a low forecast of 0.909 CAD and a high forecast of 0.945 CAD.

Lowest
Price Target
0.909 CAD
198% Upside
Average
Price Target
0.918 CAD
201% Upside
Highest
Price Target
0.945 CAD
210% Upside
Microbix Biosystems Inc Competitors:
Price Targets
LTRN
Lantern Pharma Inc.
554% Upside
AKBA
Akebia Therapeutics Inc
102% Upside
PEB
Pacific Edge Ltd
21% Downside
GILD
Gilead Sciences Inc
5% Upside
301207
Hualan Biological Bacterin Inc
17% Upside
BIOCON
Biocon Ltd
18% Upside
1801
Innovent Biologics Inc
15% Downside
IMNM
Immunome Inc
177% Upside

Revenue
Forecast

Revenue Estimate
Microbix Biosystems Inc

For the last 13 years the compound annual growth rate for Microbix Biosystems Inc's revenue is 11%. The projected CAGR for the next 3 years is 22%.

11%
Past Growth
22%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Microbix Biosystems Inc

The compound annual growth rate of Microbix Biosystems Inc's operating income for the next 1 year is 141%.

N/A
Past Growth
141%
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Microbix Biosystems Inc

The compound annual growth rate of Microbix Biosystems Inc's net income for the next 3 years is 41%.

N/A
Past Growth
41%
Estimated Growth
Estimates Accuracy
-31%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MBX's stock price target?
Price Target
0.918 CAD

According to Wall Street analysts, the average 1-year price target for MBX is 0.918 CAD with a low forecast of 0.909 CAD and a high forecast of 0.945 CAD.

What is Microbix Biosystems Inc's Revenue forecast?
Projected CAGR
22%

For the last 13 years the compound annual growth rate for Microbix Biosystems Inc's revenue is 11%. The projected CAGR for the next 3 years is 22%.

What is Microbix Biosystems Inc's Operating Income forecast?
Projected CAGR
141%

The compound annual growth rate of Microbix Biosystems Inc's operating income for the next 1 year is 141%.

What is Microbix Biosystems Inc's Net Income forecast?
Projected CAGR
41%

The compound annual growth rate of Microbix Biosystems Inc's net income for the next 3 years is 41%.

Back to Top